Connection
Ping-Ching Hsu to Neoplasm Metastasis
This is a "connection" page, showing publications Ping-Ching Hsu has written about Neoplasm Metastasis.
|
|
Connection Strength |
|
 |
|
 |
|
0.040 |
|
|
|
-
Huang SH, Huang AC, Wang CC, Chang WC, Liu CY, Pavlidis S, Ko HW, Chung FT, Hsu PC, Guo YK, Kuo CS, Yang CT. Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control. Thorac Cancer. 2019 12; 10(12):2274-2281.
Score: 0.040